Access cutting-edge colorectal cancer treatment through this clinical trial at a research site in Orlando. Study-provided care at no cost to qualified participants.
Access colorectal cancer specialists in Orlando at no cost
This study follows strict safety protocols and ethical guidelines
All study-related colorectal cancer treatment provided free
This is a trial of Regorafenib in combination with pembrolizumab for patients with MSI-H colorectal cancer consisting of lead-in phase examining preliminary efficacy and safety, followed by a randomized phase to further examine efficacy.
Sponsor: Ibrahim Halil Sahin
Check if you qualify for this colorectal cancer clinical trial in Orlando, FL
If you're searching for colorectal cancer treatment options in Orlando, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orlando research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.